Myriad Genetics (MYGN) Debt Ratio (2016 - 2026)

Myriad Genetics (MYGN) has 10 years of Debt Ratio data on file, last reported at 0.18 in Q1 2026.

• Debt Ratio for Q1 2026 came in at 0.18, up 202.96% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.18 (up 202.96% YoY), and the FY2025 annual result was 0.17, up 340.33% from the prior year.
• Debt Ratio improved to 0.18 in Q1 2026 per MYGN's latest filing, from 0.17 in the prior quarter.
• Over five years, Debt Ratio peaked at 0.18 in Q1 2026 and troughed at 0.03 in Q2 2023.
• A 4-year average of 0.08 and a median of 0.04 in 2024 frame the typical range for Debt Ratio.
• The sharpest annual moves came in 2024 and 2025: Debt Ratio increased 7.65% in 2024, then surged 355.05% in 2025.
• A 4-year view of Debt Ratio shows it stood at 0.03 in 2023, then gained by 14.76% to 0.04 in 2024, then jumped by 340.33% to 0.17 in 2025, then gained by 5.23% to 0.18 in 2026.
• Business Quant data shows MYGN's Debt Ratio at 0.18 in Q1 2026, 0.17 in Q4 2025, and 0.16 in Q3 2025.